FDA Approved: SUMATRIPTAN — Original Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approves Padagis Israel Pharmaceuticals Ltd's SUMATRIPTAN as an original ANDA generic for the acute treatment of migraines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Sumatriptan (Sumatriptan)

Snippet

ORIG AP for SUMATRIPTAN (SUMATRIPTAN)